Dicyclomine Hydrochloride
Product Images NDC 66336-911

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dicyclomine Hydrochloride (NDC 66336-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ndc 66336-0911-xx (Ndc 66336 0911 Xx Patheon)

Ndc 66336-0911-xx (Ndc 66336 0911 Xx Patheon)
This is a description of pharmaceutical capsules containing Dicyclomine HCI 10 mg. The capsules are in a clear dark blue hard gelatin, imprinted with 'Watson 794' on the cap and 10 mg on body with white ink. It is manufactured by Patheon Pharmaceuticals INC., Cincinnati, OH 45237, and is dispensed in a tight/light-resistant container with a pedigree number of 23065506. The product is associated with potential side effects such as dizziness, drowsiness, blurred vision, and dry mouth. It is only dispensed for the prescription, and its lot number is Sample EXP: 00-00 with an NDC of 66336-0911-XX, and an RX number of 29648167. The product is packaged by Dispensing Solutions in Santa Ana, CA 92704.*
FDA Label Image

Dicyclomine Hydrochloride Structural Formula (Dicyclomine HCl Caps And Tabs 1)

Dicyclomine Hydrochloride Structural Formula (Dicyclomine HCl Caps And Tabs 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.